GlaxoSmithKline is preparing to sell billions worth of swine flu drugs this year. ... stockpiling large supplies of GSK's anti-viral treatment Relenza. ...Link:http://www.spokesman.com/blogs/hbo/2010/mar/19/sali-speaks-out/
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status